Commentary

Direct-to-patient telemedicine has benefits for providers, patients, and the practice


 

Gains for the provider, the care team, and the practice

Endocrinologists can derive benefit from telemedicine engagement with their patients, which could have positive implications for other members of the care team and for the practice as a whole. For the provider, being able to streamline clinical workflows and increase practice efficiency can help reduce personal and workplace-related stress and translate into greater personal satisfaction in one’s work and delivery of better-quality care.

At the practice level, the use of telemedicine presents opportunities for expanding the patient base and perhaps working more flexible hours to better accommodate the personal and professional time demands on providers and their staff. In addition, offering telemedicine as a medium of consultation could be a practice differentiator that could give you a competitive edge. That, along with smaller changes, such as enhancing or even reducing space utilization, could contribute to reduced overheads and a boost in revenue, which would have a positive impact on the practice’s bottom line.

Getting started

There is important groundwork to be done before a telemedicine program can get underway. First, bear in mind that there is considerable state-based variation in regulations and insurance coverage, so you need to be sure that you are in compliance with the requirements for your state. If direct-to-patient telemedicine is not widely reimbursed in your state, direct-payment models may be feasible. Providers who accept Medicare payments need to understand restrictions on self-payment for those patients. You may also be able to negotiate with payers to include reimbursement for telemedicine visits in your contracts. Negotiation with payers and direct-pay models may be possible.

Key guidelines. In addition to understanding your state’s regulations around telemedicine, there are specific aspects of practice about which you need to be clear, for example:

  • You must be licensed in the state in which your patient is located at the time of their visit.
  • Understand any restrictions on prescribing via telemedicine in your state.
  • Be aware that Medicare has very specific guidelines and, at this time, does not recognize home as a place of service.
  • You must be sure that you use HIPAA-compliant video software.
  • If in any doubt, seek guidance from an attorney or your organization’s compliance office.

Infrastructure and outlay. Your infrastructure needs will depend on the specific services that you provide, but in general, you should include a communication platform and video conferencing equipment; sufficient bandwidth and a secure, reliable Internet connection; ready access to sound IT support; and comprehensive staff training at the outset, with subsequent refresher training sessions on a regular basis. Within the practice, you will need to think about adjustments to your existing workflow to accommodate the telemedicine services you plan to offer.

Resources. Two nonprofit groups that offer nonpartisan guidance in telemedicine are the Center for Connected Health Policy and the Regional Telehealth Resource Centers.

Dr. Griffith is assistant professor of medicine and medical director, Ambulatory Telehealth Services, Vanderbilt University Medical Center, in Nashville, Tenn. This article is part of a series based on presentations from the annual meeting of the Endocrine Society in March 2019. Dr. Griffith has no disclosures. Write to her at cenews@mdedge.com.

Pages

Recommended Reading

Diabetes patients pushed into high-deductible plans
Type 2 Diabetes ICYMI
Analysis shows ‘Devil’s bargain’ in cardiac arrest
Type 2 Diabetes ICYMI
Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Management
Type 2 Diabetes ICYMI
ABIM sued over maintenance of certification
Type 2 Diabetes ICYMI
EHRs and Burnout
Type 2 Diabetes ICYMI
Cerebral small vessel and cognitive impairment
Type 2 Diabetes ICYMI
Prenatal valproate and ADHD
Type 2 Diabetes ICYMI
Lower prices drive OTC insulin sales at Walmart
Type 2 Diabetes ICYMI
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
Type 2 Diabetes ICYMI
How innovation can bring more joy to your work
Type 2 Diabetes ICYMI